Mara Dauterman
About Mara Dauterman
Mara Dauterman is the Global Biocompatibility Manager at Teleflex in Morrisville, NC, with extensive experience in preclinical testing for combination drug-devices and a background in Medicinal and Biological Chemistry.
Global Biocompatibility Manager at Teleflex
Mara Dauterman currently holds the position of Global Biocompatibility Manager at Teleflex. She has been in this role since September 2021, focusing on ensuring the biocompatibility of medical devices. Teleflex is located in Morrisville, NC. Her work involves adherence to relevant regulatory standards such as 21 CFR 58 (GLP) and ISO 10993, contributing significantly to patient safety by overseeing biocompatibility assessments.
Professional Experience at BD
Mara Dauterman worked at BD for various positions from 2016 to 2021 in the Raleigh-Durham, North Carolina Area. She was Manager I, Biological Sciences for 8 months in 2021. Before that, she was a Senior Scientist from 2018 to 2021 and Scientist II from 2017 to 2018. She also served as a Biocompatibility Data Coordinator from 2016 to 2017. Her responsibilities included biological sciences management, leading scientific research, and coordinating data related to biocompatibility.
Career at NAMSA
Mara Dauterman held multiple roles at NAMSA between 2010 and 2016 in Northwood, Ohio. She was Medical Research Manager from 2015 to 2016, Study Coordinator from 2013 to 2015, Histology Technician from 2011 to 2013, and Animal Care Technician from 2010 to 2011. At NAMSA, her duties spanned medical research management, coordinating studies, and performing histological and animal care tasks.
Educational Background
Mara Dauterman studied Medicinal and Biological Chemistry at The University of Toledo, earning a Bachelor of Science (B.S.) in Pharmaceutical Sciences from 2008 to 2011. Her academic training equipped her with a comprehensive background in the chemical and biological principles underpinning medical and pharmaceutical sciences.
Expertise in Preclinical Testing and Regulations
Mara Dauterman has extensive experience in preclinical testing for combination drug-devices. She possesses a working knowledge of regulatory standards such as 21 CFR 58 (GLP) and ISO 10993. Her expertise contributes to the development and validation of new medical therapies, ensuring they meet safety and efficacy standards prior to reaching patients.